UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

Molecular aspects of medicine, 2019-02, Vol.65, p.37-55

2019

Volltextzugriff (PDF)

ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis

International journal of molecular sciences, 2019-06, Vol.20 (11), p.2700

2019

Volltextzugriff (PDF)

Pathophysiology of Organ and Tissue Fibrosis

Molecular aspects of medicine, 2019-02, Vol.65, p.1-1

2019

Volltextzugriff (PDF)

Redox mechanisms in hepatic chronic wound healing and fibrogenesis

Fibrogenesis & tissue repair, 2008-10, Vol.1 (1), p.5-5, Article 5

2008

Volltextzugriff (PDF)

SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers

Exploration of Digestive Diseases, 2024-02, Vol.3 (1), p.22-41

2024

Volltextzugriff (PDF)

Hypoxia,angiogenesis and liver fibrogenesis in the progression of chronic liver diseases

World journal of gastroenterology : WJG, 2010-01, Vol.16 (3), p.281-288

2010

Volltextzugriff (PDF)

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis

Cells (Basel, Switzerland), 2021-07, Vol.10 (7), p.1764

2021

Volltextzugriff (PDF)

Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease

Antioxidants & redox signaling, 2010-06, Vol.12 (12), p.1383-1430

2010

Volltextzugriff (PDF)

Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies

International journal of molecular sciences, 2018-12, Vol.19 (12), p.3875

2018

Volltextzugriff (PDF)

Liver fibrogenic cells

Baillière's best practice & research. Clinical gastroenterology, 2011-04, Vol.25 (2), p.207-217

2011

Volltextzugriff (PDF)

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

Molecular aspects of medicine, 2024-02, Vol.95, p.101231-101231, Article 101231

2024

Volltextzugriff (PDF)

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis

Molecular metabolism (Germany), 2024-03, Vol.81, p.101889-101889, Article 101889

2024

Volltextzugriff (PDF)

Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells

Carcinogenesis (New York), 2008-12, Vol.29 (12), p.2267-2278

2008

Volltextzugriff (PDF)

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis

PloS one, 2017-03, Vol.12 (3), p.e0172575-e0172575

2017

Volltextzugriff (PDF)

Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness

Expert opinion on therapeutic targets, 2014-02, Vol.18 (2), p.121-135

2014

Volltextzugriff (PDF)

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis

Frontiers in immunology, 2024-02, Vol.15, p.1342404-1342404

2024

Volltextzugriff (PDF)

Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data

PloS one, 2016-09, Vol.11 (9), p.e0162644-e0162644

2016

Volltextzugriff (PDF)

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis

Antioxidants, 2022-06, Vol.11 (7), p.1278

2022

Volltextzugriff (PDF)

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease

Frontiers in immunology, 2022-07, Vol.13, p.910526-910526

2022

Volltextzugriff (PDF)

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells

Hepatology (Baltimore, Md.), 2005-12, Vol.42 (6), p.1339-1348

2005

Volltextzugriff (PDF)

The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells

The Journal of pathology, 2012-03, Vol.226 (4), p.588-597

2012

Volltextzugriff (PDF)

Organ Fibrosis: Emerging diagnostic and therapeutic strategies

Molecular aspects of medicine, 2024-04, Vol.96, p.101259-101259, Article 101259

2024

Volltextzugriff (PDF)

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity

Scientific reports, 2015-12, Vol.5 (1), p.17701, Article 17701

2015

Volltextzugriff (PDF)

SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells

Scientific reports, 2017-06, Vol.7 (1), p.3420-10, Article 3420

2017

Volltextzugriff (PDF)

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness

Biology (Basel, Switzerland), 2023-05, Vol.12 (6), p.771

2023

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(209)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis

Pathophysiology of Organ and Tissue Fibrosis

Redox mechanisms in hepatic chronic wound healing and fibrogenesis

SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers

Hypoxia,angiogenesis and liver fibrogenesis in the progression of chronic liver diseases

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis

Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease

Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies

Liver fibrogenic cells

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis

Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis

Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis

Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells

The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells

Organ Fibrosis: Emerging diagnostic and therapeutic strategies

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity

SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness

Suchergebnisse filtern